Novartis Cosentyx receives FDA approval for treatment of children and adolescents with moderate to severe plaque psoriasis

NEXT STORY
COVID-19 Pipeline Diversifies as the COVID-19 Cases Soar and Demand for Effective Therapies Balloons | DelveInsight
PREV STORY
Agenus to Participate in Fireside Chat at the Jefferies 2021 Virtual Healthcare Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2015 Financial Results Conference Call and Webcast

CAMBRIDGE, Mass., Feb. 05, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology ...

author_avatar
NASDAQ Market News

ALGAE DYNAMICS CORP SECURES BULK CANNABIS SUPPLY AGREEMENT FOR COLLABORATION PARTNERS

TORONTO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- ALGAE DYNAMICS CORP (OTC: “ADYNF”) (the "Company"), ...

author_avatar
NASDAQ Market News

Landmark Health Hosts Grand Opening

ALBANY, N.Y., June 24, 2016 (GLOBE NEWSWIRE) -- House calls are making a comeback ...

author_avatar
NASDAQ Market News